This content is machine translated Non-small cell lung cancer with EGRF mutation. New approval for osimertinib for adjuvant therapy Following convincing results from the Phase III ADAURA study, the indication for osimertinib was expanded in Switzerland. Thus, the drug may now also be used for adjuvant therapy in early-stage…
View Post 2 min This content is machine translated Hormone receptor-positive breast carcinoma New option for adjunctive therapy The GnRH agonist triptorelin has been used successfully for some time in various areas, including the treatment of hormone-dependent prostate cancer. The drug is now also approved for adjuvant therapy…
View Post 6 min This content is machine translated Inflammatory dermatoses Not only the right wavelength is decisive Laser medicine applications as second-line or adjuvant therapy can be a valuable addition to the treatment spectrum for inflammatory dermatoses. For best possible results, treatment decisions must be weighed on…
View Post 9 min This content is machine translated Adjuvant system therapy of breast carcinoma Current standards of adjuvant therapy according to tumor subtype Adjuvant systemic treatment improves survival and freedom from recurrence in early breast cancer. Genetic testing of the tumor can help in the choice of therapy. Supportive monitoring is useful even…
View Post 8 min This content is machine translated Therapy for gastrointestinal stromal tumors Surgical and oncological aspects Before initiating therapy, GIST patients should be discussed at an interdisciplinary tumor board. For intermediate to high risk of relapse, adjuvant imatinib therapy should be considered after resection. Patients with…
View Post 5 min This content is machine translated How to proceed with chronic wounds? Assessment, dressings and adjuvant therapy Chronic wounds are a major challenge for primary care providers. The reasons for this are the diverse causes of wounds, the patient’s desire for rapid treatment success and, last but…
View Post 5 min This content is machine translated Early detection begins in the family doctor's office Melanocytic nevi and malignant melanoma Melanocytic nevi are the most common benign neoplasms in fair skin types. Their number is a risk indicator for the development of malignant melanoma, of which they may be precursors.…
View Post 12 min This content is machine translated Non-small cell lung cancer Individualized, palliative first-line therapy is possible Therapy for non-small cell lung cancer is individualized and based on tumor stage, histology, and predictive molecular markers, taking into account the patient profile. To maximize the therapeutic outcome for…
